114 related articles for article (PubMed ID: 24523215)
21. Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection.
Price JC; Ma Y; Scherzer R; Korn N; Tillinghast K; Peters MG; Noworolski SM; Tien PC
Hepatology; 2017 Mar; 65(3):853-863. PubMed ID: 27981599
[TBL] [Abstract][Full Text] [Related]
22. Liver-related mortality and hospitalizations attributable to chronic hepatitis C virus coinfection in persons living with HIV.
Mena A; Meijide H; Rodríguez-Osorio I; Castro A; Poveda E
HIV Med; 2017 Oct; 18(9):685-689. PubMed ID: 28230318
[TBL] [Abstract][Full Text] [Related]
23. Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort study.
Weis N; Lindhardt BO; Kronborg G; Hansen AB; Laursen AL; Christensen PB; Nielsen H; Moller A; Sorensen HT; Obel N
Clin Infect Dis; 2006 May; 42(10):1481-7. PubMed ID: 16619163
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients.
Fernández-Montero JV; Vispo E; Barreiro P; Sierra-Enguita R; de Mendoza C; Labarga P; Soriano V
Clin Infect Dis; 2014 Jun; 58(11):1549-53. PubMed ID: 24633686
[TBL] [Abstract][Full Text] [Related]
25. Cause-specific excess mortality in siblings of patients co-infected with HIV and hepatitis C virus.
Hansen AB; Lohse N; Gerstoft J; Kronborg G; Laursen A; Pedersen C; Sørensen HT; Obel N
PLoS One; 2007 Aug; 2(8):e738. PubMed ID: 17710138
[TBL] [Abstract][Full Text] [Related]
26. HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality.
Klein MB; Rollet KC; Saeed S; Cox J; Potter M; Cohen J; Conway B; Cooper C; Côté P; Gill J; Haase D; Haider S; Hull M; Moodie E; Montaner J; Pick N; Rachlis A; Rouleau D; Sandre R; Tyndall M; Walmsley S;
HIV Med; 2013 Jan; 14(1):10-20. PubMed ID: 22639840
[TBL] [Abstract][Full Text] [Related]
27. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
d'Arminio Monforte A; Cozzi-Lepri A; Castagna A; Antinori A; De Luca A; Mussini C; Caputo SL; Arlotti M; Magnani G; Pellizzer G; Maggiolo F; Puoti M;
Clin Infect Dis; 2009 Aug; 49(4):612-22. PubMed ID: 19591597
[TBL] [Abstract][Full Text] [Related]
28. Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol.
Salmon-Ceron D; Lewden C; Morlat P; Bévilacqua S; Jougla E; Bonnet F; Héripret L; Costagliola D; May T; Chêne G;
J Hepatol; 2005 Jun; 42(6):799-805. PubMed ID: 15973779
[TBL] [Abstract][Full Text] [Related]
29. Neuropsychiatric impact of hepatitis C on advanced HIV.
Ryan EL; Morgello S; Isaacs K; Naseer M; Gerits P;
Neurology; 2004 Mar; 62(6):957-62. PubMed ID: 15037699
[TBL] [Abstract][Full Text] [Related]
30. Risk of echocardiographic pulmonary hypertension in individuals with human immunodeficiency virus-hepatitis C virus coinfection.
Sangal RB; Taylor LE; Gillani F; Poppas A; Klinger JR; Ventetuolo CE
Ann Am Thorac Soc; 2014 Dec; 11(10):1553-9. PubMed ID: 25375659
[TBL] [Abstract][Full Text] [Related]
31. [1977 mortality rate in HIV-infected patients presenting with hepatitis C cirrhosis. Results of the GERMIVC multicenter survey conducted in French departments of internal medicine or infectious disease].
Geffray L; Rosenthal E; Cacoub P; Perronne C; Veyssier P; Raguin G; Cevallos R; Patey O; Bouchard O; Loury I; Delarocque E; Goujard C; Estavoyer JM; Dupont C; Grappin M; Morand P; Laurichesse H; Vuitton D
Rev Med Interne; 1999 Dec; 20(12):1082-7. PubMed ID: 10635069
[TBL] [Abstract][Full Text] [Related]
32. Structural Bone Deficits in HIV/HCV-Coinfected, HCV-Monoinfected, and HIV-Monoinfected Women.
Lo Re V; Lynn K; Stumm ER; Long J; Nezamzadeh MS; Baker JF; Hoofnagle AN; Kapalko AJ; Mounzer K; Zemel BS; Tebas P; Kostman JR; Leonard MB
J Infect Dis; 2015 Sep; 212(6):924-33. PubMed ID: 25754980
[TBL] [Abstract][Full Text] [Related]
33. Impact of hepatitis B on mortality and specific causes of death in adults with and without HIV co-infection in NYC, 2000-2011.
Pinchoff J; Tran OC; Chen L; Bornschlegel K; Drobnik A; Kersanske L; Fuld J
Epidemiol Infect; 2016 Dec; 144(16):3354-3364. PubMed ID: 27510414
[TBL] [Abstract][Full Text] [Related]
34. Temporal trends in mortality among people who use drugs compared with the general Dutch population differ by hepatitis C virus and HIV infection status.
van Santen DK; van der Helm JJ; Grady BP; de Vos AS; Kretzschmar ME; Stolte IG; Prins M
AIDS; 2014 Nov; 28(17):2589-99. PubMed ID: 25211439
[TBL] [Abstract][Full Text] [Related]
35. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy.
Tedaldi EM; Baker RK; Moorman AC; Alzola CF; Furhrer J; McCabe RE; Wood KC; Holmberg SD;
Clin Infect Dis; 2003 Feb; 36(3):363-7. PubMed ID: 12539079
[TBL] [Abstract][Full Text] [Related]
36. Treatment of chronic hepatitis C in human immunodeficiency virus/hepatitis C virus-coinfected patients in the era of pegylated interferon and ribavirin.
Bräu N
Semin Liver Dis; 2005 Feb; 25(1):33-51. PubMed ID: 15731996
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and mapping of hepatitis C infections among men who have sex with men in New York City.
Tieu HV; Laeyendecker O; Nandi V; Rose R; Fernandez R; Lynch B; Hoover DR; Frye V; Koblin BA
PLoS One; 2018; 13(7):e0200269. PubMed ID: 30020960
[TBL] [Abstract][Full Text] [Related]
38. Effect of liver fibrosis on long-term mortality in HIV/hepatitis C virus-coinfected individuals who are evaluated to receive interferon therapies in the highly active antiretroviral therapy era.
Sanmartin R; de Felipe E; Tor J; Sanvicens A; Barluenga E; Martinez E; Muga R; Jou A; Ojanguren I; López JJ; Clotet B; Tural C
AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1235-43. PubMed ID: 22443303
[TBL] [Abstract][Full Text] [Related]
39. High hepatic and extrahepatic mortality and low treatment uptake in HCV-coinfected persons in the Swiss HIV cohort study between 2001 and 2013.
Kovari H; Ledergerber B; Cavassini M; Ambrosioni J; Bregenzer A; Stöckle M; Bernasconi E; Kouyos R; Weber R; Rauch A;
J Hepatol; 2015 Sep; 63(3):573-80. PubMed ID: 25937433
[TBL] [Abstract][Full Text] [Related]
40. Expression of inhibitory markers is increased on effector memory T cells during hepatitis C virus/HIV coinfection as compared to hepatitis C virus or HIV monoinfection.
Saha B; Choudhary MC; Sarin SK
AIDS; 2013 Sep; 27(14):2191-200. PubMed ID: 23820090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
